Диссертация (1140393), страница 22
Текст из файла (страница 22)
2004. V. 28. P. 199-207.150219. Murtezaoglu AR, Gucer H. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19 // Pol J Pathol. 2017. V. 68(1). P. 1-10.220. Nagpal R, Kaushal M, Kumar S. Cytological diagnosis of an uncommonhigh grade malignant thyroid tumor: a case report // J Clin Diagn Res. 2017.V.
7. P. 3-5.221. Nilsson M, Fagman H. Development of the thyroid gland // Development.2017. V. 12. P. 2123-2140.222. Papillary thyroid cancer case masked by subacute thyroiditis / Ucan B.,Delibasi T., Cakal E. [et al.] // Arq Bras Endocrinol Metabol. 2014. V. 58(8).P. 851-854.223.
Papillary thyroid carcinoma with honeycomb-like multiple small cysts:characteristic features on ultrasonography / Kobayashi K., Hirokawa M.,Yabuta T. [et al.] // Eur Thyroid J. 2013. V. 2(4). P. 270-274.224. Patterns of cyclin A and B1 immunostaining in papillary thyroid carcinoma /Cyniak-Magierska A., Stasiak M. [et al.] // Annals of Agricultural and Environmental Medicine. 2015. V. 22.
P. 741–746.225. Petric R., Besic H., Besic N. Preoperative serum thyroglobulin concentrationas a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland // World J Surg Oncol. 2014. V. 48(5). P. 589592.226. Popoveniuc G., Jonklaas J. Thyroid nodules // Med Clin North Am. 2012. V.96(2). P. 329-349.227. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology / Alexander E.K., Kennedy G.C., Baloch Z.W.
[et al.] // N Engl J Med.2012. V. 367(8). P. 705-715.228. Prevalence of anti-thyroid peroxidase in adults with type 1 diabetes participating in Poznań Prospective Study / Grzelka A., Araszkiewicz A., UruskaA., Zozulińska-Ziółkiewicz D. // Adv Clin Exp Med. 2015. V. 24(1). P. 7984.151229. Proteomic profiling of follicular and papillary thyroid tumors / Sofiadis A.,Becker S., Hellman U.
[et al.] // Eur J Endocrinol. 2012. V. 166(4). P. 657667.230. Risk of thyroid cancer based on thyroid ultrasound imaging characteristics:results of a population-based study / Smith-Bindman R., Lebda P., FeldsteinV.A. [et al.] // JAMA Intern Med. 2013. V. 173(19). P. 1788-1796.231. Role of GPER1, EGFR and CXCR1 in differentiating between malignantfollicular thyroid carcinoma and benign follicular thyroid adenoma / LeZhao, Xiao-Yun Zhu [et al.] // Int J Clin Exp Pathol. 2015. V. 8(9) Р. 1123611247.232. Saika K., Matsuda T., Sobue T. Incidence rate of thyroid cancer by histological type in Japan // Jpn J Clin Oncol.
2014. V. 44(11). P. 1131-1132.233. Selenium supplementation alleviates autoimmune thyroiditis by regulatingexpression of TH1/TH2 cytokines / Tan L., Sang Z.N., Shen J. [et al.] // Biomed Environ Sci. 2013. V. 26(11). P. 920-925.234. Somatostatin receptor expression in non-medullary thyroid carcinomas / Pazaitou-Panayiotou K., Tiensuu Janson E., Koletsa T. [et al.] // Hormones(Athens). 2012. V.
11(3). P. 290-296.235. Sorafenib in metastatic thyroid cancer / Capdevila J., Iglesias L., Halperin I.[et al.] // Endocr Relat Cancer. 2012. V. 19(2). P. 209-216.236. Study of the histological profile of papillary thyroid carcinomas associatedwith Hashimoto's thyroiditis / Cordioli M.I., Cury A.N., Nascimento A.O.,Oliveira A.K., Mello M., Saieg M.A. // Arq Bras Endocrinol Metabol. 2013.V.
57(6). P. 445-449.237. Takano T. Natural history of thyroid cancer [Review] // Endocr J. 2017. V.64(3). P. 237-244.238. The histological rarity of thyroid cancer / Vianna D.M., Curioni O.A., França L.J. [et al.] // Braz J Otorhinolaryngol. 2012. V. 78(4).
P. 48-51.152239. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas / Kim C., Bi X., Pan D., Chen Y., CarlingT., Ma S., Udelsman R., Zhang Y. // Thyroid. 2013. V. 23(5). P. 575-82.240. Three-gene molecular diagnostic model for thyroid cancer / Prasad N.B.,Kowalski J., Tsai H.L. [et al.] // Thyroid. 2012.
V. 22(3). P. 275-284.241. Threshold primary tumour sizes for nodal and distant metastases in papillaryand follicular thyroid cancers / Zaman Mu, Fatima N., Sajjad Z. [et al.] //Asian Pac J Cancer Prev. 2012. V. 13(6). P. 2473-2476.242. Thyroid autoantibodies are rare in nonhuman great apes and hypothyroidismcannot be attributed to thyroid autoimmunity / Aliesky H., Courtney C.L.,Rapoport B., McLachlan S.M. // Endocrinology.
2013. V. 154(12). P. 48964907.243. Thyroid dysfunction: an autoimmune aspect / Khan F.A., Al-Jameil N.,Khan M.F., Al-Rashid M., Tabassum H. // Int J Clin Exp Med. 2015. V.8(5). P. 6677-6681.244. Thyroid hormone and anti-apoptosis in tumor cells / Lin H.Y., Glinsky G.V.,Mousa S.A., Davis P.J. // Oncotarget. 2015. V. 6(17). P. 14735-14743.245. Thyroid nodule surgery: predictive diagnostic value of fine-needle aspirationcytology and frozen section / Prades J.M., Querat C., Dumollard J.M. [et al.]// Eur Ann Otorhinolaryngol Head Neck Dis.
2013. V. 130(4). P. 195-199.246. Thyroid papillary carcinoma associated to Hashimoto's thyroiditis / CamposL.A., Picado S.M., Guimarães A.V., Ribeiro D.A., Dedivitis R.A. // Braz JOtorhinolaryngol. 2012. V. 78(6) P. 77-80.247. Variations of weight of thyroid gland in different age and sex groups ofbangladeshi cadavers / Sultana R., Khan M.K., Mannan S. [et al.] // Mymensingh Med J. 2015. V.
24(3). P. 497-501.153.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
